Over the last few weeks, I created a computer game set in the Arctic. Or maybe I've been working on it since 1981. It all depends on how you count. All I know for sure is that I programmed the ...

SEE ALSO: 'Stranger Things' fans are furious about the finale. Here's why. The Stranger Things finale brought the series to an end late last month, wrapping up the popular retro sci-fi show after ...

We didn’t just track DX headlines in 2025 — we traveled to get the context behind them. Here’s what stood up to reality. By the end of 2025, the digital experience industry had moved past the most ...

Sarah Bradley is a writer with six years of experience creating personal essays, reported features, and content related to health and parenting topics. Susan Bard, MD, is a board-certified general and ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

A United States District Court judge on Thursday ruled that the Federal Emergency Management Agency (FEMA) was wrong to cancel a program that has funded infrastructure resiliency efforts in ...

If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...

President Trump is pushing for an intensified “reverse migration” agenda across his administration, seeking to broaden a crackdown on millions of immigrants from poorer countries following the killing ...

The U.S. Centers for Disease Control and Prevention has instructed staffers to end all monkey research, according to a report in Science. The decision will affect studies involving some 200 macaques; ...

A growing number of special education teachers say they use artificial intelligence platforms to draft all or part of students’ individualized education programs, even as many districts lack policies ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...